We invite you to explore the links below to find out more about commercial litigation, intellectual property, mesothelioma cancer, pharmaceutical (drug) liability, product liability, toxic exposures and wrongful death!
Also: state regulators look like David to the health insurance industry's Goliath; two steps forward in regenerative medicine; how Medicare Advantage cuts may play out.
Also: Other cities may mimic San Francisco's cellphone law; Merck reports positive results for hepatitis C drug; Alzheimer's criteria developers defend their proposal.
Also: NJ suit on involuntary medication; FDA wants to clarify device-approval process; Consumer Reports identifies supplement ingredients with scary side effects.